DPC423
DPC423 is a selective and orally active factor Xa inhibitor with a Kis of 0.15 (human) and 0.3 (rabbit) nM. DPC423 exhibits Kis of 60, 61 and 6000 nM against human trypsin, plasma kallikrein and thrombin. DPC423 blocks the formation of prothrombinase complex, reduces thrombin production, inhibits fibrin formation and platelet activation. DPC423 can be used for the study of anticoagulation of arterial thrombosis.
For research use only. We do not sell to patients.
- CAS No.: 292135-59-2
- Formula: C25H21ClF4N4O3S
- Molecular Weight:568.97
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
DPC423 (1-10 mg/kg, p.o., single dose) exhibits a dose-dependent anti-thrombotic effect[1][2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:
-
Dosage:0.08, 0.25, 0.82 and 2.5 mg/kg
-
Administration:Intravenous injection (i.v.), for 90 min
-
Result:Completely prevented thrombosis within 90 minutes when administered at a rate of 2.5 mg/kg/h intravenously.
Dose-dependent increased in the time of arterial patency with an EC₅₀ value (effective plasma concentration) of 137 nM.
-
Animal Model:
-
Dosage:1, 3 and 10 mg/kg
-
Administration:Oral administration (p.o.), single dose
-
Result:Oral dose-dependent antithrombotic effect, with a significant result achieved at 10 mg/kg.
Chemical Information
-
CAS No. 292135-59-2
-
Molecular Weight 568.97
-
Formula C25H21ClF4N4O3S
-
SMILES
NCC1=CC(N2C(C(NC3=CC=C(C4=CC=CC=C4S(=O)(C)=O)C=C3F)=O)=CC(C(F)(F)F)=N2)=CC=C1.Cl
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
[1]. D J Pinto, et al. Discovery of 1-[3-(aminomethyl)phenyl]-N-3-fluoro-2'-(methylsulfonyl)-[1,1'-biphenyl]-4-yl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide (DPC423), a highly potent, selective, and orally bioavailable inhibitor of blood coagulation factor Xa. J Med Chem. 2001 Feb 15;44(4):566-78. [Content Brief]
[2]. Wong PC, et al. Nonpeptide factor Xa inhibitors III: effects of DPC423, an orally-active pyrazole antithrombotic agent, on arterial thrombosis in rabbits. J Pharmacol Exp Ther. 2002 Dec;303(3):993-1000. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)